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Purpose: The anatomic and biomechanical properties of peri-articular
bone play a primary role in the dispersion of loading forces across the
joint. 30-50% of a load across a knee is absorbed by peri-articular bone
compared to only 1-3% by articular cartilage. Attenuation of loading
forces by peri-articular bone is critical in protecting articular cartilage
from damage. However, thickening of subchondral bone and disruption
of peri-articular trabecular architecture occur early in osteoarthritis
(OA), and may even antedate cartilage damage. The purpose of this
study is to evaluate whether relative periarticular bone mineral density
is associated with MRI-assessed articular cartilage damage.
Methods: This is a study nested within an ancillary study to the
Osteoarthritis Initiative (OAI). We selected a sample enriched with
participants likely to have cartilage damage over time. Due to logistics
of deploying the study within an ongoing observational study, the visit
for the dual x-ray absorptiometry (DXA) measurements was the OAI 30
or 36 month visit and the visits for cartilage assessments were the OAI
24 and 48month visits. DXAs of the knee generated twomeasurements,
medial tibial or periarticular bone mineral density (medial paBMD) and
medial:lateral periarticular bone mineral density (M:L paBMD) meas-
ures, using proprietary software. DH measured the cartilage damage
index (CDI) in the medial tibiofemoral compartment 3T MRI acquired
DESS sequences. The CDI is a parsimoniousmeasure of cartilage damage
in 9 informative regions in the medial tibiofemoral cartilage. Only
evaluating the one knee per person, we created scatter plots and per-
formed Pearson's correlations of the periarticular bone mineral density
assessments and (1) the 24 month CDI assessments and (2) rate of
change in CDI deﬁned as the CDI difference between 24 and 48 months
divided by the time elapsed between those visits.
Results: 130 participants were included in the study with a mean age of
64 þ9.1 years, 53% were male, mean BMI was 30.1 þ4.8 kg/m2. At the
OAI 24 month visit, 6 (5%) had a Kellgren Lawrence score of 0, 11 (9%)
with a score of 1, 35 (26%) with a score of 2, and 78 (60%) with a score of
3 and 1 (1%) with a score of 4.
The relationships between relative periarticular bone mineral density
and CDI were stronger than those evaluating absolute bone mineral
density.
Conclusions: Higher relative periarticular BMD is associated with
greater articular cartilage damage in the medial tibiofemoral cartilage
damage cross sectionally and longitudinally. Because we were able to
ﬁnd this association, this study also additionally provides construct
validity to the cartilage damage index as a parsimonious measurement
of articular cartilage. This study highlights the close relationship
between periarticular bone and articular cartilage.
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Purpose: Articular cartilage is an avascular tissue by nature, in which
resident chondrocytes maintain a stable phenotype that is resistant to
hypertrophy and angiogenesis throughout life. Hypoxia is known to
stabilize hypoxia-inducible factor-a (mainly HIF-1a and HIF-2a) and
initiate an angiogenic signalling cascade. However, normal cartilage
maintains avascularity under hypoxic conditions; and the abrogation of
avascularity in cartilage is related to several joint diseases such as
osteoarthritis (OA), indicating the important role of anti-angiogenic
factors in normal cartilage homeostasis.
Chondromodulin-1 (ChM-1) is an anti-angiogenic protein endoge-
nously expressed in cartilage and has recently been shown to stabilizethe chondrocyte phenotype during cartilage tissue repair via an
unknown mechanism. These ﬁndings suggested that anti-angiogenic
factors had a critical role in maintaining the physiological functions of
chondrocytes and prevent hypertrophy. Our aims in the present study
were to clarify the role of ChM-1 during chondrocyte maturation, OA
development and therapy, in an animal model, as well as to explore the
mechanistic pathways of ChM-1with a focus of the regulation of the HIF
pathways.
Methods: ChM-1 expression during chondrocyte maturation was
investigated in chondrogenic culture conditions in cells derived from
cartilage and bone marrow. Lentivirus vectors carrying ChM-1 com-
plementary DNA (LV-ChM-1) and ChM-1 siRNA were constructed to
respectively over-express and down-regulate ChM-1. Human OA carti-
lage samples were collected and subjected to gene proﬁling of angio-
genic and anti-angiogenic cytokines using Human Angiogenesis PCR
Arrays (Qiagen, Australia). Tumor necrosis factor alpha (TNFa) was
applied to mimic the inﬂammatory environment in OA. Articular car-
tilage cells (ACCs) over-expressing or under-expressing ChM-1 were
exposed to TNFa, and the chondrogenic and hypertrophic markers
(RUNX2, COL10, MMP13, ALP and VEGF) were assayed by qRT-PCR and
western blot. To evaluate the effect of ChM-1 in OA development, an OA
model was created in rats by surgical sectioning of themeniscus. For the
mechanistic study, intracellular protein levels, nuclear accumulation
and transcriptional activity of HIF-2a with ChM overexpression were
evaluated by western blot and Chromatin-Immunoprecipitation (ChIP)
assay, respectively.
Results: Compared with healthy cartilage, the expression of angiogenic
factors was signiﬁcantly upregulated and anti-angiogenic factors were
suppressed in OA cartilage (Figure 1A). ChM-1 expression was strongly
correlated with chondrogenesis in cells derived from both cartilage and
bone marrow. In OA cartilage, the Angiogenesis PCR Array revealed
decreased gene expression in the majority of anti-angiogenic factors,
whereas the gene expression of angiogenic-related cytokines increased
(Figure 1B). ACCs over-expressing ChM-1 appeared to protect chon-
drocytes from TNFa induced hypertrophy, and was commensurate with
decreased gene and protein level of MMP13, COL10 and VEGF; whereas
siRNA-decreased ChM-1 levels resulted in the loss of chondrogenic
marker expression and chondrocytes undergoing hypertrophy and
becomingmore sensitive to inﬂammatory cytokines. LV-ChM-1 induced
over-expression of ChM-1 in the rat model resulted in delayed OA
development. It was noted that ChM-1 delayed HIF-2a nuclear trans-
location at an early time-point and decreased the transcriptional
activity of HIF-2a on VEGF and MMP13.
Conclusions: These ﬁndings demonstrate that ChM-1 is a potent anti-
angiogenic factor that is essential to maintain the chondrocyte phe-
notype and prevent these cells from undergoing hypertrophy during OA
development by inhibition of the HIF-2amediated angiogenic pathway.
Thus, this study shows that anti-angiogenic factors such as ChM-1 are
essential for the maintenance of chondrocyte homeostasis, prevent
hypoxia induced angiogenesis in cartilage, and protect chondrocyte
from inﬂammatory cytokines induced hypotrophy.
